Cargando…
Breast Cancer Patients: Who Would Benefit from Neoadjuvant Chemotherapies?
Neoadjuvant chemotherapy (NACT) was developed with the aims of shrinking tumors or stopping cancer cells from spreading before surgery. Unfortunately, not all breast cancer patients will benefit from NACT, and thus, patients must weigh the risks and benefits of treatment prior to the initiation of t...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320700/ https://www.ncbi.nlm.nih.gov/pubmed/35877249 http://dx.doi.org/10.3390/curroncol29070389 |